ACOFP Gathers Experts at Chronic Disease Summit
06 Apr 2026 //
PHARMIWEB
FDA Approves BRAVECTO® QUANTUM from Merck Animal Health
18 Mar 2026 //
PHARMIWEB
NMPA Approves Promega MSI Kit as KEYTRUDA Companion Diagnostic
03 Feb 2026 //
PHARMIWEB
Study: One-Third of Trial Data May Be Unnecessary
19 Sep 2025 //
FIERCE BIOTECH
Merck Animal Health`s Bravecto® Quantum Gets FDA Approval
10 Jul 2025 //
BUSINESSWIRE
Merck Animal Health gets EU CVMP nod for Numelvi
12 Jun 2025 //
BUSINESSWIRE
Merck to Join Bank of America 2025 Healthcare Conference
07 May 2025 //
BUSINESSWIRE
Dawn Health, Merck Launch Digital Ecosystem for Growth Disorders
07 May 2025 //
PR NEWSWIRE
Merck Manuals to Power Microsoft Copilot Health Agent
14 Apr 2025 //
PR NEWSWIRE
Merck, Zebra Partner On Safety & Traceability Solutions
27 Mar 2025 //
INDPHARMAPOST
First Patient Dosed In Immutep’s Ph III NSCLC Trial
25 Mar 2025 //
GLOBENEWSWIRE
Merck to Participate in the Jefferies London Healthcare Conference
14 Nov 2024 //
BUSINESSWIRE
Amgen And Merck Join Academic Clinical Trial Diversity Initiative
16 Sep 2024 //
FIERCE BIOTECH
How Merck Scientists Are Driving Next-Generation Cancer Research
06 Jun 2024 //
ACCESSWIRE
Global threat of antibiotic resistance highlighted in film supported by Pfizer
01 Sep 2023 //
#N/A
COVID-19 antiviral treatment shown to speed up recovery in trial
23 Dec 2022 //
PHARMAFILE
Lynparza On Track For Broad Frontline Use In Prostate Cancer
15 Feb 2022 //
THE PINK SHEET
COVID-19 pills are coming, but no substitute for vaccines, disease experts say
08 Nov 2021 //
REUTERS
Two months after inking a SPAC deal, Renovacor taps new CMO
05 Jun 2021 //
ENDPTS
Changing the whole game of drug discovery`: Legendary R&D vet Roger
06 May 2021 //
ENDPTS
Dean Li invites another under-the-radar biotech to Merck`s dealmaking as Amathus
18 Mar 2021 //
ENDPTS
Pfizer/BioNTech release real-world evidence of vaccine efficacy; EMA
11 Mar 2021 //
ENDPTS
Dean Li kicks off Merck`s post-Roger Perlmutter era by teaming with Artiva
28 Jan 2021 //
ENDPTS
Dean Li kicks off Merck`s post-Roger Perlmutter era by teaming with Artiva
28 Jan 2021 //
ENDPTS
How technology companies are leveraging the pharmaceutical ecosystem
21 Jan 2021 //
BIOSPECTRUMASIA
R&D exec faces up to 10 years in prison on charges stole “thousands” of top
14 Jan 2021 //
ENDPTS
Pan-adjuvant` use will fuel PD-1 sales growth: report
03 Dec 2020 //
FIERCE PHARMA
PARP combo shows promise in ovarian and breast cancer models
26 Oct 2020 //
FIERCEBIOTECH
Vaccine sales driven down by pandemic`s effects on doctor visits
31 Jul 2020 //
BIOPHARMADIVE
Coronavirus vaccine developers make case to Congress they can win public`s trust
21 Jul 2020 //
BIOPHARMADIVE
Burned by Alzheimer’s failures, a cautious Merck turns to a startup biotech
24 Jun 2020 //
ENDPTS
Why Drug Companies May Resist Milking Covid-19 Treatments
10 Jun 2020 //
WSJ
India will have to play key role in mass production of coronavirus vaccine
24 May 2020 //
ECONOMIC TIMES
Battling low expectations and goliath rivals, Regeneron/Sanofi add +ve Libtayo
04 May 2020 //
ENDPTS
Big Pharma Will Turn to Mergers After Crisis, Says RBC
24 Apr 2020 //
BARRONS
High prices fuel pharma profits. New research provides more context
03 Mar 2020 //
BIOPHARMADIVE
Experts doubtful of Idorsia’s daridorexant uptake potential in insomnia
27 Jan 2020 //
CLINICALTRIALSARENA
Gates vets at Adjuvant back Codagenix`s software-driven approach
13 Jan 2020 //
ENDPTS
Biotech is beating health care by double this year—here’s how one investor
10 Dec 2019 //
CNBC
Survey shows “lack of knowledge” about diabetes risks
14 Nov 2019 //
PHARMA TIMES
Ebola trial stopped early as Regeneron, Ridgeback therapies cut death risk
12 Aug 2019 //
ENDPTS
Vaccination against cervical cancer virus impacts stopping infections.
27 Jun 2019 //
REUTERS
ACC: Merck anacetrapib reveal bodes neutral at best for DalCor
20 Mar 2019 //
FIERCE BIOTECH
Merck puts prostate cancer firmly in Keytruda’s sights
15 Feb 2019 //
PM LIVE
FDA Grants Priority Review to Merck’s sBLA for Keytruda+Inlyta for RCC
15 Feb 2019 //
BIOSPACE
Bayer, Orion prostate cancer drug cuts risk of metastasis by > 50%, study
15 Feb 2019 //
ENDPTS
Cerecor Announces CERC-301 Granted U.S. Patent
15 Feb 2019 //
GLOBENEWSWIRE
New cancer drugs help upbeat AstraZeneca beat forecasts
15 Feb 2019 //
REUTERS
Merck to further study Keytruda in prostate cancer after early success
15 Feb 2019 //
REUTERS
Keytruda combo outshines Opdivo in kidney cancer
13 Feb 2019 //
PM LIVE
Bavencio combo gets FDA priority review for kidney cancer
13 Feb 2019 //
PHARMA TIMES
Merck’s Prevnar challenger nabs FDA ‘breakthrough’ tag, Should Pfizer worry?
05 Feb 2019 //
FIERCE PHARMA
OncoSec Provides KEYNOTE-695 Clinical Update And Outlines 2019 Milestones
01 Feb 2019 //
PR NEWSWIRE
First phase 3 data back Scynexis` new-class antifungal
31 Jan 2019 //
FIERCE BIOTECH
Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
22 Jan 2019 //
BIOSPACE
Dragonfly preps clinical takeoff, inking a collaboration pact with MD Anderson
18 Jan 2019 //
ENDPTS
Merck highlights crucial hit for Keytruda in second-line esophageal carcinoma
16 Jan 2019 //
ENDPTS
Keytruda reduces risk of death compared to chemo
15 Jan 2019 //
PHARMA TIMES
A Planned Spinoff Of Cancer Vaccines At Generex
14 Jan 2019 //
SEEKING ALPHA
Merck`s Keytruda slashes death risk by 31% in esophageal cancer victory
14 Jan 2019 //
FIERCE PHARMA

Market Place
Sourcing Support